Ardent Health Inc (ARDT) Institutional Investor Snapshot (140 Funds, Q2 2026)

ARDT ranks #3837 out of 37501 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

ARDT is a top-conviction position for Ventas, Inc. — at 100.0% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in ARDT belongs to Chai Trust Co LLC, but the position matters far more to Ventas, Inc., who has 100.0% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Ameriprise Financial Inc has added to its ARDT position for two straight quarters, increasing it by $10.9M to reach $20.8M today.

Israel Englander has trimmed its ARDT position for two straight quarters, cutting it by $7.0M while still holding $472.4K.

ARDT is down 0.3% today, but institutions show net buying of $22.7M this quarter — a divergence between today's price move and the underlying institutional flow.

ARDT posted net income of $78.2M over the trailing twelve months, and currently trades at a P/E of 19.7.

• Profitable — net income of $78.2M over the trailing twelve months
• Revenue grew 3.3% year over year
• Net income declined year over year, from $254.9M to $78.2M
• Generated $470.5M in positive operating cash flow
• Current ratio of 1.97x — enough short-term assets to cover short-term liabilities
• Liabilities run 2.14x equity — a highly leveraged balance sheet worth noting